地西他滨用于治疗恶性血液肿瘤的临床价值分析
【摘要】 目的 分析地西他滨用于治疗恶性血液肿瘤的临床价值。方法 110例恶性血液肿瘤患者作为研究对象， 随机分为观察组和对照组， 每组55例。其中观察组患者采用地西他滨治疗， 对照组患者采用吉西他滨治疗， 观察两组的临床疗效和不良反应。结果 观察组治疗总有效率45.5%明显优于对照组21.8%；观察组不良反应发生率45.5%明显低于对照组70.9%， 差异具有统计学意义(P<0.05)。结论 地西他滨治疗恶性血液肿瘤疾病具有显著疗效， 不良反应发生率低， 具有积极的临床推广价值。
【关键词】 地西他滨；恶性血液肿瘤；吉西他滨
DOI：10.14163/j.cnki.11-5547/r.2015.22.017
Analysis of clinical value of decitabine in the treatment of hematological malignancies YAO Kai-tao， CHEN Jiang-sheng， CHEN Chun-li. The Second Affiliated Hospital of Medical College of Shantou University， Shantou 515041， China
【Abstract】 Objective To analyze clinical value of decitabine in the treatment of hematological malignancies. Methods A total of 110 hematological malignancies patients as study subjects were randomly divided into observation group and control group ......
您现在查看是摘要页，全文长 4991 字符。
【关键词】 地西他滨；恶性血液肿瘤；吉西他滨
DOI：10.14163/j.cnki.11-5547/r.2015.22.017
Analysis of clinical value of decitabine in the treatment of hematological malignancies YAO Kai-tao， CHEN Jiang-sheng， CHEN Chun-li. The Second Affiliated Hospital of Medical College of Shantou University， Shantou 515041， China
【Abstract】 Objective To analyze clinical value of decitabine in the treatment of hematological malignancies. Methods A total of 110 hematological malignancies patients as study subjects were randomly divided into observation group and control group ......
您现在查看是摘要页，全文长 4991 字符。